{
    "title": "Drug Addiction Treatment Act of 1999",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Drug Addiction Treatment Act of \n1999''.\n\nSEC. 2. AMENDMENT TO CONTROLLED SUBSTANCES ACT.\n\n    Section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) \nis amended--\n            (1) in paragraph (2), by striking ``(A) security'' and \n        inserting ``(i) security'', and by striking ``(B) the \n        maintenance'' and inserting ``(ii) the maintenance'';\n            (2) by redesignating paragraphs (1) through (3) as \n        subparagraphs (A) through (C), respectively;\n            (3) by inserting ``(1)'' after ``(g)'';\n            (4) by striking ``Practitioners who dispense'' and \n        inserting ``Except as provided in paragraph (2), practitioners \n        who dispense''; and\n            (5) by adding at the end the following:\n            ``(2)(A) Subject to subparagraphs (D) and (G), the \n        requirements of paragraph (1) are waived in the case of the \n        dispensing, by a practitioner, of narcotic drugs in schedule IV \n        or V or combinations of such drugs if the practitioner meets \n        the conditions specified in subparagraph (B) and the narcotic \n        drugs or combinations of such drugs meet the conditions \n        specified in subparagraph (C).\n            ``(B) For purposes of subparagraph (A), the conditions \n        specified in this subparagraph with respect to a practitioner \n        are that, before dispensing narcotic drugs in schedule IV or V, \n        or combinations of such drugs, to patients for maintenance or \n        detoxification treatment, the practitioner submit to the \n        Secretary a notification of the intent of the practitioner to \n        begin dispensing the drugs or combinations for such purpose, \n        and that the notification contain the following certifications \n        by the practitioner:\n                    ``(i) The practitioner is a physician licensed \n                under State law, and the practitioner has, by training \n                or experience, the ability to treat and manage opiate-\n                dependent patients.\n                    ``(ii) With respect to patients to whom the \n                practitioner will provide such drugs or combinations of \n                drugs, the practitioner has the capacity to refer the \n                patients for appropriate counseling and other \n                appropriate ancillary services.\n                    ``(iii) In any case in which the practitioner is \n                not in a group practice, the total number of such \n                patients of the practitioner at any one time will not \n                exceed the applicable number. For purposes of this \n                clause, the applicable number is 20, except that the \n                Secretary may by regulation change such total number.\n                    ``(iv) In any case in which the practitioner is in \n                a group practice, the total number of such patients of \n                the group practice at any one time will not exceed the \n                applicable number. For purposes of this clause, the \n                applicable number is 20, except that the Secretary may \n                by regulation change such total number, and the \n                Secretary for such purposes may by regulation establish \n                different categories on the basis of the number of \n                practitioners in a group practice and establish for the \n                various categories different numerical limitations on \n                the number of such patients that the group practice may \n                have.\n            ``(C) For purposes of subparagraph (A), the conditions \n        specified in this subparagraph with respect to narcotic drugs \n        in schedule IV or V or combinations of such drugs are as \n        follows:\n                    ``(i) The drugs or combinations of drugs have, \n                under the Federal Food, Drug and Cosmetic Act or \n                section 351 of the Public Health Service Act, been \n                approved for use in maintenance or detoxification \n                treatment.\n                    ``(ii) The drugs or combinations of drugs have not \n                been the subject of an adverse determination. For \n                purposes of this clause, an adverse determination is a \n                determination published in the Federal Register and \n                made by the Secretary, after consultation with the \n                Attorney General, that the use of the drugs or \n                combinations of drugs for maintenance or \ndetoxification treatment requires additional standards respecting the \nqualifications of practitioners to provide such treatment, or requires \nstandards respecting the quantities of the drugs that may be provided \nfor unsupervised use.\n            ``(D)(i) A waiver under subparagraph (A) with respect to a \n        practitioner is not in effect unless (in addition to conditions \n        under subparagraphs (B) and (C)) the following conditions are \n        met:\n                    ``(I) The notification under subparagraph (B) is in \n                writing and states the name of the practitioner.\n                    ``(II) The notification identifies the registration \n                issued for the practitioner pursuant to subsection (f).\n                    ``(III) If the practitioner is a member of a group \n                practice, the notification states the names of the \n                other practitioners in the practice and identifies the \n                registrations issued for the other practitioners \n                pursuant to subsection (f).\n                    ``(IV) A period of 30 days has elapsed after the \n                date on which the notification was submitted, and \n                during such period the practitioner does not receive \n                from the Secretary a written notice that one or more of \n                the conditions specified in subparagraph (B), \n                subparagraph (C), or this subparagraph, have not been \n                met.\n            ``(ii) The Secretary shall provide to the Attorney General \n        such information contained in notifications under subparagraph \n        (B) as the Attorney General may request.\n            ``(E) If in violation of subparagraph (A) a practitioner \n        dispenses narcotic drugs in schedule IV or V or combinations of \n        such drugs for maintenance treatment or detoxification \n        treatment, the Attorney General may, for purposes of section \n        304(a)(4), consider the practitioner to have committed an act \n        that renders the registration of the practitioner pursuant to \n        subsection (f) to be inconsistent with the public interest.\n            ``(F) In this paragraph, the term `group practice' has the \n        meaning given such term in section 1877(h)(4) of the Social \n        Security Act.\n            ``(G)(i) This paragraph takes effect on the date of \n        enactment of the Drug Addiction Treatment Act of 1999, and \n        remains in effect thereafter except as provided in clause (iii) \n        (relating to a decision by the Secretary or the Attorney \n        General that this paragraph should not remain in effect).\n            ``(ii) For the purposes relating to clause (iii), the \n        Secretary and the Attorney General shall, during the 3-year \n        period beginning on the date of enactment of the Drug Addiction \n        Treatment Act of 1999, make determinations in accordance with \n        the following:\n                    ``(I)(aa) The Secretary shall--\n                            ``(aaa) make a determination of whether \n                        treatments provided under waivers under \n                        subparagraph (A) have been effective forms of \n                        maintenance treatment and detoxification \n                        treatment in clinical settings;\n                            ``(bbb) make a determination regarding \n                        whether such waivers have significantly \n                        increased (relative to the beginning of such \n                        period) the availability of maintenance \n                        treatment and detoxification treatment; and\n                            ``(ccc) make a determination regarding \n                        whether such waivers have adverse consequences \n                        for the public health.\n                    ``(bb) In making determinations under this \n                subclause, the Secretary--\n                            ``(aa) may collect data from the \n                        practitioners for whom waivers under \n                        subparagraph (A) are in effect;\n                            ``(bb) shall promulgate regulations (in \n                        accordance with procedures for substantive \n                        rules under section 553 of title 5, United \n                        States Code) specifying the scope of the data \n                        that will be required to be provided under this \n                        subclause and the means through which the data \n                        will be collected; and\n                            ``(cc) shall, with respect to collecting \n                        such data, comply with applicable provisions of \n                        chapter 6 of title 5, United States Code \n                        (relating to a regulatory flexibility analysis) \n                        and of chapter 8 of such title (relating to \n                        congressional review of agency rulemaking).\n                    ``(II) The Attorney General shall--\n                            ``(aa) make a determination of the extent \n                        to which there have been violations of the \n                        numerical limitations established under \n                        subparagraph (B) for the number of individuals \n                        to whom a practitioner may provide treatment;\n                            ``(bb) make a determination regarding \n                        whether waivers under subparagraph (A) have \n                        increased (relative to the beginning of such \n                        period) the extent to which narcotic drugs in \n                        schedule IV or V or combinations of such drugs \n                        are being dispensed or possessed in violation \n                        of this Act; and\n                            ``(cc) make a determination regarding \n                        whether such waivers have adverse consequences \n                        for the public health.\n            ``(iii) If, before the expiration of the period specified \n        in clause (ii), the Secretary or the Attorney General publishes \n        in the Federal Register a decision, made on the basis of \n        determinations under such clause, that this paragraph should \n        not remain in effect, this paragraph ceases to be in effect 60 \n        days after the date on which the decision is so published. The \n        Secretary shall, in making any such decision, consult with the \n        Attorney General, and shall, in publishing the decision in the \n        Federal Register, include any comments received from the \n        Attorney General for inclusion in the publication. The Attorney \n        General shall, in making any such decision, consult with the \n        Secretary, and shall, in publishing the decision in the Federal \n        Register, include any comments received from the Secretary for \n        inclusion in the publication.\n            ``(H) During the 3-year period beginning on the date of \n        enactment of the Drug Addiction Treatment Act of 1999, a State \n        may not preclude a practitioner from dispensing narcotic drugs \n        in schedule IV or V, or combinations of such drugs, to patients \n        for maintentance or detoxification treatment in accordance with \n        the Drug Addiction Treatment Act of 1999, unless, before the \n        expiration of that 3-year period, the State enacts a law \n        prohibiting a practitioner from dispensing such drugs or \n        combination of drugs.''.\n    (e) Conforming Amendment.--Section 304 of the Controlled Substances \nAct (21 U.S.C. 824) is amended--\n            (1) in subsection (a), in the matter following paragraph \n        (5), by striking ``section 303(g)'' each place the term appears \n        and inserting ``section 303(g)(1)''; and\n            (2) in subsection (d), by striking ``section 303(g)'' and \n        inserting ``section 303(g)(1)''."
}